Search research articles
Contact Us
Filters
Showing results (1-10 of 174) with videos related to
Page
of 18
Sort By:
Case Reports in Oncology
|
May 9, 2022
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases
Vittorio Gebbia
Tumori
|
March 10, 2009
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma]
Vittorio Gebbia
Expert Opinion on Pharmacotherapy
|
May 14, 2008
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
Vittorio Gebbia
Expert Opinion on Drug Safety
|
August 23, 2005
Oral versus intravenous vinorelbine: clinical safety profile
Vittorio Gebbia, Christian Puozzo
La Tunisie Medicale
|
January 25, 2006
Chemotherapy for endometrial carcinoma
Vittorio Gebbia, Roberta Agueli
World Journal of Clinical Cases
|
July 10, 2024
Metastatic clear cell sarcoma of the pancreas: A sporadic cancer
Vittorio Gebbia, Carlo Carnaghi
BMJ Supportive & Palliative Care
|
September 26, 2022
Cancer survivors: long-term opioid therapy - the challenge
Sebastiano Mercadante, Yasmine Grassi, Vittorio Gebbia
Critical Reviews in Oncology/Hematology
|
June 21, 2011
Spinal analgesia for advanced cancer patients: an update
Sebastiano Mercadante, Giampiero Porzio, Vittorio Gebbia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
New opioids
Sebastiano Mercadante, Giampiero Porzio, Vittorio Gebbia
Frontiers in Oncology
|
June 29, 2026
Editorial: Challenges and strategies in the management of ER/PgR Low-expression breast cancer: exploring fundamentals, clinical insights, and treatment approaches
Takashi Takeshita, Vittorio Gebbia, San-Gang Wu
Page
of 18
Search research articles
Search
Showing results (1-10 of 174) with videos related to
Sort By:
Page
of 18
Case Reports in Oncology
|
May 9, 2022
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases
Vittorio Gebbia
Tumori
|
March 10, 2009
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma]
Vittorio Gebbia
Expert Opinion on Pharmacotherapy
|
May 14, 2008
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
Vittorio Gebbia
Expert Opinion on Drug Safety
|
August 23, 2005
Oral versus intravenous vinorelbine: clinical safety profile
Vittorio Gebbia, Christian Puozzo
La Tunisie Medicale
|
January 25, 2006
Chemotherapy for endometrial carcinoma
Vittorio Gebbia, Roberta Agueli
World Journal of Clinical Cases
|
July 10, 2024
Metastatic clear cell sarcoma of the pancreas: A sporadic cancer
Vittorio Gebbia, Carlo Carnaghi
BMJ Supportive & Palliative Care
|
September 26, 2022
Cancer survivors: long-term opioid therapy - the challenge
Sebastiano Mercadante, Yasmine Grassi, Vittorio Gebbia
Critical Reviews in Oncology/Hematology
|
June 21, 2011
Spinal analgesia for advanced cancer patients: an update
Sebastiano Mercadante, Giampiero Porzio, Vittorio Gebbia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
New opioids
Sebastiano Mercadante, Giampiero Porzio, Vittorio Gebbia
Frontiers in Oncology
|
June 29, 2026
Editorial: Challenges and strategies in the management of ER/PgR Low-expression breast cancer: exploring fundamentals, clinical insights, and treatment approaches
Takashi Takeshita, Vittorio Gebbia, San-Gang Wu
Page
of 18